Taylor, Cottrill, Erickson & Associates, Inc. Lemaitre Vascular Inc Transaction History
Taylor, Cottrill, Erickson & Associates, Inc.
- $282 Million
- Q4 2024
A detailed history of Taylor, Cottrill, Erickson & Associates, Inc. transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Taylor, Cottrill, Erickson & Associates, Inc. holds 3,275 shares of LMAT stock, worth $284,925. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,275
Previous 3,270
0.15%
Holding current value
$284,925
Previous $303,000
0.66%
% of portfolio
0.11%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding LMAT
# of Institutions
309Shares Held
20.7MCall Options Held
3.6KPut Options Held
2.9K-
Black Rock Inc. New York, NY3.48MShares$302 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.69MShares$147 Million2.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$137 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.17MShares$102 Million2.06% of portfolio
-
Geneva Capital Management LLC866KShares$75.3 Million1.4% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $1.91B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...